Putting patients first

Insmed is here to help throughout the patient journey

Arikares Support Program icon

Living with refractory MAC lung disease can be challenging, so Insmed is proud to offer patient-centric programs and resources to help MAC patients navigate reimbursement barriers, treatment access, education, and training.

Arikares Support Program

Supporting ARIKAYCE patients throughout their journey

Doctor icon

Enroll in Arikares

Complete the Arikares™ Enrollment Form to prescribe ARIKAYCE and enroll patients in the Arikares Support Program

Arikares Coordinator icon

Arikares Coordinators

Arikares Coordinators can assist patients with payer navigation, information, prior authorizations, and prescription access

Patient support icon

Patient Support

Arikares Coordinators can help patients appropriately take their therapy as prescribed

Delivering ARIKAYCE truck icon

Starting ARIKAYCE

The Arikares Coordinator and the specialty pharmacy will work with patients to coordinate the shipment of ARIKAYCE to their home

Nebulizer training icon

Patient Education

Arikares Trainers (nurses and respiratory therapists) may provide in-home training at treatment initiation and during the patient’s first dose, getting them familiar with nebulizing ARIKAYCE and integrating it into their daily routine

Mobile phone icon

Ongoing Support

Arikares can provide patients with ongoing support during their course of care

Arikares enrollment form icon

Support starts with you

Complete the Arikares Enrollment Form with your patients to get started

Download
Download arrow icon

the Arikares Enrollment Form

Savings and financial support

Committed to patient care and access

Insmed is committed to providing access to ARIKAYCE. To learn more about potential savings and financial support options, Arikares Coordinators are available to answer questions at 1-833-ARIKARE (1-833-274-5273), or at 1-973-437-2376.

Phone icon

To discuss reimbursement or affordability, please call 1-833-ARIKARE (1-833-274-5273), or 1-973-437-2376, Monday through Friday from 8 am to 8 pm Eastern Time.

ARIKAYCE Co-pay Savings Program*

  • Eligible patients using private or commercial insurance can save on out-of-pocket costs for ARIKAYCE
  • Not valid for prescriptions covered by or submitted for reimbursement under Medicaid, Medicare, VA, DoD, TRICARE or similar federal or state programs, including any state pharmaceutical assistance program
  • Eligibility can be determined by calling Arikares at 1-833-ARIKARE (1-833-274-5273), or at 1-973-437-2376

DoD=Department of Defense; VA=Veterans Affairs.

Medicare Part D extra help—LIS program

Medicare patients who have limited income and resources may qualify for extra help to pay for medication. The LIS, or "Extra Help," program from Medicare provides financial assistance for patients who may not be able to afford the costs associated with their Medicare Part D plan.

Those who are eligible for LIS may:

  • Receive assistance paying their monthly minimum
  • Have a reduced or no deductible
  • Have a reduced or no prescription coinsurance and co-payments
  • Have no gap in coverage
Learn more about the LIS program

State-sponsored programs

Some states sponsor prescription financial assistance programs, each with its own eligibility requirements.

Learn more about state pharmaceutical assistance programs

Footnote

These programs are not offered by Insmed.

LIS=Low-Income Subsidy.

Additional resources

Arikares Enrollment Form

Sample Letter of Medical Necessity

Sample Appeals Letter

ARIKAYCE Co-pay Savings Program Terms and Conditions

Most patients who are eligible pay $0 co-pay every month up to a $32,000 maximum program benefit per calendar year, and subject to a monthly program benefit limit of $8,000 per month. Patient will be responsible for any co-pay once limit is reached. Depending on the private or commercial health insurance plan, savings may apply toward co-pay, coinsurance, or deductible.

Who is eligible?

Patients who have been prescribed ARIKAYCE, are at least 18 years of age, a resident of the 50 United States, the District of Columbia, or Puerto Rico, and have commercial or private health insurance may be eligible for the ARIKAYCE Co-pay Savings Program. ARIKAYCE must be covered by the patient’s commercial or private insurance. This Program is not valid for cash-paying customers. This offer is not valid for prescriptions covered by or submitted for reimbursement under Medicaid, Medicare, VA, DoD, TRICARE or similar federal or state programs, including any state pharmaceutical assistance program.

Patients who are currently ineligible for the ARIKAYCE Co-pay Savings Program may reapply if their circumstances change.

This is not an insurance benefit, and does not cover or provide support for supplies, procedures, or any physician-related services associated with ARIKAYCE. General, non-product specific insurance deductibles above the amount set forth above are also not covered. Insmed reserves the right to rescind, revoke, terminate, or amend this offer, eligibility, and terms and conditions at any time without notice. Patients, pharmacists, and prescribers cannot seek reimbursement from health insurance or any third party for any part of the benefit received by the patient through this offer. This offer is not conditioned on any past, present, or future purchase, including refills. The co-pay card is non-transferable, limited to one per person, and cannot be combined with any other offer or discount. This program is not valid where prohibited by law, taxed, or restricted. Offer has no cash value.

MAC=Mycobacterium avium complex.